WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction.
No Thumbnail Available
Date
2008-05-13
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
BACKGROUND Less than 63 of individuals with diabetes meet professional guidelines target of hemoglobin A1c Under7 0 and only 7 meet combined glycemic lipid and blood pressure goals The primary study aim was to assess the impact on A1c of a cell phone based diabetes management software system used with web based data analytics and therapy optimization tools Secondary aims examined health care provider HCP adherence to prescribing guidelines and assessed HCPs adoption of the technology METHODS Thirty patients with type 2 diabetes were recruited from three community physician practices for a 3 month study and evenly randomized The intervention group received cell phone based software designed by endocrinologists and CDEs WellDoc Communications Inc Baltimore MD The software provided real time feedback on patients blood glucose levels displayed patients medication regimens incorporated hypo and hyperglycemia treatment algorithms and requested additional data needed to evaluate diabetes management Patient data captured and transferred to secure servers were analyzed by proprietary statistical algorithms The system sent computer generated logbooks with suggested treatment plans to intervention patients HCPs RESULTS The average decrease in A1c for intervention patients was 2 03 compared to 0 68 P Under 0 02 one tailed for control patients Of the intervention patients 84 had medications titrated or changed by their HCP compared to controls 23 P 0 002 Intervention patients HCPs reported the system facilitated treatment decisions provided organized data and reduced logbook review time CONCLUSIONS Adults with type 2 diabetes using WellDoc s software achieved statistically significant improvements in A1c HCP and patient satisfaction with the system was clinically and statistically significant
Description
Keywords
At risk for a particular disease or infection, Client, Access to information or data, Continuity of care, Low adherence to treatments, Pilot, Efficacy, Randomized, Experimental, Non-communicable diseases, Diabetes, Chronic care, Treatment adherence, Disease management, Electronic decision support, Data collection and reporting, Surveillance, Raw data, Physiologic Biosensors, Digital protocol